Search

… Job Title Research Technician Email [email protected] Lab Phone 646-888-2362

If you or someone you know has been diagnosed with cancer, contact our Patient Access Service for an appointment. No referral necessary.

… Meet Our Care Advisors If you or someone you know has been diagnosed with cancer, contact our Patient Access Service for an appointment at one of  our locations  or from your own home via  telemedicine . No referral necessary. It’s natural to be anxious when you reach out to us and you may have a lot

… Trainee Statistics View the Therapeutic Medical Physics Residency trainee program statistics. Residency Program Statistics View Therapeutic Medical Physics Residency trainee statistics.

Learn how Kéara was able to maintain her quality of life after treatment for triple negative breast cancer.

… Monday, April 4, 2022 When Kéara Richardson was diagnosed with triple-negative breast cancer at just 37, she feared her life would never be the same again. But Memorial Sloan Kettering Cancer Center (MSK) offered her an innovative treatment that puts chemotherapy before breast cancer surgery . This approach

… Not So Fast: Dividing Cells Use a “Speed Limit” to Avoid Genetic Mistakes

Scientists are learning how tumors develop resistance to drugs — and what can be done about it.

… Thursday, July 27, 2017 Summary Drugs targeting a particular mutation in cancer cells can be an effective form of therapy. But the beneficial effects are often short-lived as tumors quickly develop resistance. New research is casting light on how this resistance evolves and what treatment approaches

Learn about liver tumors in children and why MSK Kids is the best place for your child’s care.

… Liver cancer and tumors in children are rare, but their complexity can make them challenging to treat. At MSK Kids, our pediatric liver tumor specialists have extensive experience performing liver tumor surgery and customizing chemotherapy treatments when needed. We also have expertise in caring for

Memorial Sloan Kettering’s Bob Li served as principal investigator of the CodeBreaK 100 trial, the largest clinical trial conducted to date exclusively for patients with the KRAS G12C mutation.

… Tuesday, June 1, 2021 The U.S. Food and Drug Administration (FDA) has announced an accelerated approval of sotorasib (Lumakras™) for the treatment of adult patients with  KRAS  G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC). Memorial Sloan Kettering’s Bob Li served as

تقدم هذه المعلومات الصادرة عن شركة Vertex® معلومات حول دواء كاسجفي [[Casgevy®] (إكساغامغلوغين أوتوتيمسيل).

… تقدم هذه المعلومات الصادرة عن شركة Vertex ® معلومات حول دواء كاسجفي [[Casgevy ® ] (إكساغامغلوغين أوتوتيمسيل). انقر هناك لقراءة هذا المورد: كُتيب كاسجفي [Casgevy ® ] تفضل بزيارة الموقع https://www.casgevy.com/sites/default/files/casgevy-brochure-SCD-arabic… للاطلاع على هذا المورد.